Precautions when taking Lorlatinib

Lorlatinib is a targeted drug used to treat non-small cell lung cancer (NSCLC) with mutations in ALK (tyrosine kinase) and ROS1 (kinase). During the use of lorlatinib, patients and doctors need to work closely and follow a series of medication precautions to ensure the safety and effectiveness of the treatment. Here are some important considerations about taking lorlatinib:

1. Use under physician supervision: Patients should be evaluated by a physician before using lorlatinib to ensure that the drug is the most appropriate treatment option. Doctors will develop a personalized treatment plan based on factors such as the patient's tumor characteristics, health status and treatment history.

2. Preclinical molecular testing: Before initiating lorlatinib treatment, preclinical molecular testing is usually required to determine whether the patient has an ALK or ROS1 mutation. This can help determine whether a person is a candidate for this targeted therapy and can guide doctors in developing a more precise treatment plan.

3. Dosage and usage: Patients should use lorlatinib correctly in accordance with the prescription and medication instructions prescribed by their doctor. Dosage is usually determined based on the patient's weight, liver function and other factors. Patients should ensure that they use the medication accurately as directed by their doctor and avoid adjusting the dosage on their own while taking the medication.

4. Dietary Guidance: Dietary guidance is often important as well. Patients should use the medicine within a certain period of time before or after meals according to the doctor's advice to improve the absorption effect of the medicine. In particular, some foods may interact with medications, so dietary guidance is crucial to ensure treatment is effective.

5. Regular monitoring: During treatment, doctors usually arrange regular monitoring and examinations, including blood tests, imaging examinations, etc., to evaluate the patient's disease response and drug tolerance. Patients should actively cooperate with the doctor's monitoring plan and promptly report any discomfort or abnormal symptoms.

6. Side effects management: Lorlatinib may cause some side effects, such as nausea, fatigue, headache, etc. Patients should maintain communication with their doctors during use and report any symptoms of discomfort in a timely manner. Doctors will adjust the dose or take other interventions based on the patient's specific situation to reduce side effects.

7. Drug Interactions: While taking lorlatinib, patients should inform their physician of all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements. Some drugs may interact with lorlatinib, affecting its efficacy or increasing the risk of side effects.

8. Contraindications during pregnancy and lactation: Lorlatinib may have adverse effects on pregnant and lactating women, so appropriate contraceptive measures should be taken during treatment and lactation should be avoided during treatment.

9. Heart monitoring: Because lorlatinib may have effects on the heart, your doctor may recommend an electrocardiogram and other heart monitoring to ensure stable heart function.

10. Changes in Precautions: Patients should pay close attention to the doctor's advice during medication and contact the medical team in a timely manner if they notice any changes in symptoms or discomfort. Adjustments may be made during treatment based on patient response and disease status, so timely communication is important.

In general, the use of lorlatinib requires patients to work closely with their medical team and strictly follow the doctor's recommendations and medication guidelines. Only under the supervision of a physician can patients maximize the benefits of treatment and reduce potential adverse reactions and risks.

Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. For details, please consult the local hospital pharmacy. There are original lorlatinib drugs and cheaper generic drugs abroad. The cheaper ones are the original drug from Turkey, which costs more than 1,000 yuan, and the original drug from Hong Kong, China, which costs about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.